dc.contributor.author | Aass, Kristin Roseth | |
dc.contributor.author | Nedal, Tonje Marie Vikene | |
dc.contributor.author | Bouma, Siri Anshushaug | |
dc.contributor.author | Tryggestad, Synne Stokke | |
dc.contributor.author | Haukås, Einar | |
dc.contributor.author | Slørdahl, Tobias Schmidt | |
dc.contributor.author | Waage, Anders | |
dc.contributor.author | Standal, Therese | |
dc.contributor.author | Mjelle, Robin | |
dc.date.accessioned | 2023-04-18T09:49:53Z | |
dc.date.available | 2023-04-18T09:49:53Z | |
dc.date.created | 2022-12-16T08:43:35Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | British Journal of Cancer. 2022, . | en_US |
dc.identifier.issn | 0007-0920 | |
dc.identifier.uri | https://hdl.handle.net/11250/3063526 | |
dc.language.iso | eng | en_US |
dc.publisher | Springer Nature | en_US |
dc.rights | Navngivelse 4.0 Internasjonal | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/deed.no | * |
dc.title | Comprehensive small RNA-sequencing of primary myeloma cells identifies miR-105-5p as a predictor of patient survival | en_US |
dc.title.alternative | Comprehensive small RNA-sequencing of primary myeloma cells identifies miR-105-5p as a predictor of patient survival | en_US |
dc.type | Journal article | en_US |
dc.type | Peer reviewed | en_US |
dc.description.version | publishedVersion | en_US |
dc.source.pagenumber | 0 | en_US |
dc.source.journal | British Journal of Cancer | en_US |
dc.identifier.doi | 10.1038/s41416-022-02065-1 | |
dc.identifier.cristin | 2094106 | |
dc.relation.project | Norges forskningsråd: 223255 | en_US |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 2 | |